20265 ā
Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
PPAR-ALPHA/GAMMA AGONIST FOR USE IN THE TREATMENT OF LIVER FAILURE
#2COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#3AZOLE DERIVATIVES AS SHP2 INHIBITORS
#42,4 DNP and Prodrugs Thereof for Treatment of Cancer
#5Hydrolyzed Pea Protein-Based Nutrient Composition
#6CANNABINOID ANALOGS AND METHODS OF USE FOR TREATMENT AND PREVENTION OF CANCER
#7NOVEL SUBSTITUTED QUINOLINE AND TETRAHYDRONAPHTHALENE CARBOXYLIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
#8SYNERGISTIC INTERACTIONS FOR IMPROVED CANCER TREATMENT
#9AFFINITY ILLUDOFULVENE CONJUGATES
#10BINGE BEHAVIOR REGULATORS
#11GENE THERAPY FOR BLEEDING DISORDERS
#12PHAGE AND ALLICIN COMPOSITION FOR INFECTION TREATMENT
#13CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY
#14MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#15CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Uses Thereof
#16CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
#17THERAPEUTIC AND NON-THERAPEUTIC USES OF A PERSONAL CLEANSING COMPOSITION AND METHODS OF TREATMENT
#18ASSESSING AND TREATING MULTIPLE MYELOMA
#19METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS
#20HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION
#21INHIBITORS OF UBIQUITIN SPECIFIC PEPTIDASE 22 (USP22) AND USES THEREOF FOR TREATING DISEASE AND DISORDERS
#22LFA-1 ANTAGONISTS FOR TREATING INFLAMMATORY BOWEL DIESEASE
#23QUINOLINE COMPOUND SALT OR CRYSTAL FORM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#24COMBINATION THERAPY FOR TREATMENT OF CONDITIONS ASSOCIATED WITH AGING
#25Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the Same
#26Nitroxyl donors with improved therapeutic index
#27SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENT
#28A METHOD FOR EFFICIENT MICROGLIA REPLACEMENT
#29METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
#30TARGETING ZNF410 FOR FETAL HEMOGLOBIN INDUCTION IN BETAHEMOGLOBINOPATHIES
#31COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN
#32ANTIMICROBIAL COMPOUNDS AND METHODS OF USE
#33COMPOSITION AND METHOD FOR OMEGA-3 AND PLANT FLAVONOIDS FOR INCREASING HDL CHOLESTEROL AND DECREASING LDL CHOLESTEROL AND TRIGLYCERIDE LEVELS
#34Affinity illudofulvene conjugates
#35Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
#36Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use for the treatment of cancer
#37TREATMENT OF LIVER FAILURE
#38METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS
#39ACCELERATING THE DRYING RATE OF SOFTGEL CAPSULES
#40SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENT
#41COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT
#42MICROBIOTA BASED THERAPIES TO PROMOTE MENTAL HEALTH
#43COMPOSITIONS FOR DISRUPTING BIOFILM FORMATION AND FOR TREATING BIOFILM-RELATED DISORDERS
#44CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF
#45METHOD TO DESTABALIZE CYSTEINE EXPOSED INFECTIOUS INFORMATION VECTORS
#46METHODS AND COMPOSITIONS FOR RECONSTITUTING MICROGLIA
#47COMPOSITIONS AND METHODS FOR PROVIDING CHEMOPROTECTIVE EFFECTS
#48Nitroxyl donors with improved therapeutic index
#49METHOD FOR TREATING FEMALE NON-SMOKERS WITH NON-SMALL CELL LUNG CANCER
#50MODIFIED IL-12 T CELL THERAPY FOR THE TREATMENT OF CANCER
#51Medroxyprogesterone acetate injectable compositions and methods of use
#52COMPOSITIONS COMPRISING UROLITHINS AND USES THEREOF FOR THE STIMULATION OF INSULIN SECRETION
#53MATERIALS AND METHODS FOR STOPPING RESPIRATORY VIRUS INFECTIONS
#54Combination therapy
#55USE OF INHIBITORS OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES
#56MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#57Hydrolyzed Pea Protein-Based Nutrient Composition
#58METHODS FOR HEMATOPOIETIC STEM AND PROGENITOR CELL TRANSPLANT THERAPY
#59TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
#60BINGE BEHAVIOR REGULATORS
#61BINGE BEHAVIOR REGULATORS
#62Binge behavior regulators
#63ANTI-VIRULENCE COMPOSITIONS AND METHODS
#64BUSULFAN COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#65KRAS peptide vaccine compositions and method of use
#66Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same
#67Affinity illudofulvene conjugates
#68Carbamoyl phenylalaninol analogs and uses thereof
#69ANTISEPTIC COMPOSITONS AND METHODS OF USE
#70Hydrolyzed pea protein-based nutrient composition
#71Nitroxyl donors with improved therapeutic index
#72Medicament having anti-inflammatory bowel disease function, and preparation method therefor and application thereof
#73Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
#74Inhibitors of histone lysine specific demethylase (LSD1) and histone deacetylases (HDACS)
#75CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
#76COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AND TREATMENT OF INHERITED METABOLIC DISORDERS
#77METHOD FOR THE TREATMENT OF BETA-THALASSEMIA
#78CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION
#79Compositions having ginger-curcumin and certain additives
#80Anti-virulence compositions and methods
#81Compounds and methods for inducing chondrogenesis
#82Pharmaceutical compositions comprising nitroxyl donors
#83Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion
#84INHIBITORS OF NUCLEOTIDYLTRANSFERASE SUPERFAMILY ENZYMES AS ANTIBIOTICS
#85Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#86Nitroxyl donors with improved therapeutic index
#87METHOD OF TREATING NEOPLASIAS
#88Method of treating melanoma using an inhibitor of an atypical protein kinase C
#89Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
#90Homogenous antibody drug conjugates via enzymatic methods
#91Binge behavior regulators
#92Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
#93Hydrolyzed pea protein-based nutrient composition
#94TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION
#95IL-8 INHIBITORS FOR USE IN THE TREATMENT OF SOME UROLOGICAL DISORDERS
#96Devices and methods for injectable vascular sclerofoams using a carrier matrix and uses thereof
#97Combination therapy for a stable and long term engraftment
#98Prodrugs of Chlorokynurenines
#99Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function
#100Method for Treating Obesity
#101Method for Treating Obesity
#102Methods and pharmaceutical compositions for the treatment of lung cancer
#103CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS
#104Pharmaceutical compositions comprising nitroxyl donors
#105Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
#106Use of Rad18 inhibitors in the treatment of tumors
#107Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
#108Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea
#109BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF
#110Nitroxyl donors with improved therapeutic index
#111Methods for improving cognitive function via modulation of quinone reductase 2
#112ACAT1 inhibitors for treating cancer
#113Binge behavior regulators
#114CHLORINE OR BROMINE SALTS OF CETYLPYRIDINIUM FOR USE IN THE TREATMENT OF CUTANEOUS AND ACUTE PORPHYRIAS AND PSORIASIS
#115Homogenous antibody drug conjugates via enzymatic methods
#116Homogenous antibody drug conjugates via enzymatic methods
#117Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#118PRODRUGS OF CHLOROKYNURENINES
#119COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN
#120Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#121Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#122AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER
#123Nitroxyl donors with improved therapeutic index
#124Methods and products related to glutaminase inhibitors
#125Conditioning protocols and use of same for tissue regeneration
#126Compositions and methods that modulate white blood cells or neutrophils in a companion animal
#127Treatment of graft versus host disease in transplant patients
#128COMBINATION THERAPY WITH A PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY
#129METHOD OF TREATING NEOPLASIAS
#130Compositions of additives to ginger-curcumin to facilitate growth of fibroblasts and collagen
#131Binge behavior regulators
#132Ī²-substituted Ī²-amino acids and analogs as chemotherapeutic agents
#133Method of treating leukemia based on gene expression of clock genes
#134FIBROBLAST GROWTH FACTOR (FGF) 1 MUTANTS AND METHODS OF USE TO REDUCE BLOOD GLUCOSE
#135Method for removing bacterial biofilms
#136Compositions for use in treating glioblastoma
#137Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma
#138Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals
#139Anionic linear polyglycerol derivatives, a method for manufacturing and applications
#140Ī²-substituted Ī²-amino acids and analogs as chemotherapeutic agents and uses thereof
#141Method of treating melanoma using an inhibitor of an atypical protein kinase C
#142ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS
#143RAS-INHIBITING INDENYL ACETAMIDE COMPOUNDS, COMPOSITIONS, AND USES
#144Methods for enhancing hematopoietic stem/progenitor cell engraftment
#145Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#146Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#147SODIUM TETRADECYL SULFATE FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE
#148SULFESTROL FOR TREATING CANCER
#149Novel Triarylethylene Compounds and Methods Using Same
#150Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#151Compounds for Use in Controlling Body Fat
#152Devices and methods for injectable vascular sclerofoams using a carrier matrix and uses thereof
#153Treatment of conditions through pharmacological modulation of the autonomic nervous system
#154Method for treating chemotherapy-induced male infertility
#155Homogenous antibody drug conjugates via enzymatic methods
#156Methods for improving cognitive function via modulation of quinone reductase 2
#157Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#158Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#159INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS)
#160STAT3 phosphorylation during graft-versus-host disease
#161LIGANDS THAT TARGET HEPATITIS C VIRUS E2 PROTEIN
#162Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#163METHODS OF CHEMOTHERAPY USING CHEMOTHERAPEUTIC AGENTS BASED ON BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS
#164RAC1 inhibitors of neurofibroma formation
#165Inhibitors of ERCC1-XPF and methods of using the same
#166BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS
#167Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
#168Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion
#169Compounds with (1E, 6E)-1,7-Bis-(3,4-dimethoxyphenyl)-4-4-distributed-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#170Allograft tolerance induction
#171Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
#172Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals
#173Cholesterol Ester-Depleting Nanomedicine for Non-toxic Cancer Chemotherapy
#174ANTISEPTIC COMPOSITONS AND METHODS OF USE
#175Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
#176Hydroxyalkyl starch for the treatment of hematological neoplasms
#177Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
#178Deuterated rigosertib
#179Cell-penetrating peptide and conjugate comprising same
#180extracts
#181Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function
#182Modulation of reactivation of a latent virus
#183Compounds and methods for inducing chondrogenesis
#184Aminoquinazoline derivatives and their salts and methods of use thereof
#185Nitroxyl donors with improved therapeutic index
#186TREATMENT OF GRAFT VERSUS HOST DISEASE IN TRANSPLANT PATIENTS
#187Pharmaceutical compositions comprising nitroxyl donors
#188Combination of (3S,3Sā²) 4,4ā²-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent
#189Compounds that inhibit human DNA ligases and methods of treating cancer
#190Anti-HIV compound and preparation method and use thereof
#191SULFESTROL FOR TREATING CANCER
#192Methods for enhancing hematopoietic stem/progenitor cell engraftment
#193Allograft tolerance induction
#194Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
#195FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING
#196Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#1972,5-dialkyl-4-H/halo/ether-phenol compounds
#198Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
#199Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals
#200Deuterated rigosertib
#201Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#202Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
#203METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION
#204Combination therapy for a stable and long term engraftment
#205Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#206Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#207Nutritional Composition
#208Compounds and methods for inducing chondrogenesis
#209Use of LXR antagonists for treatment of side effects of elevated glucocorticoid levels
#210Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof
#211Topical Ophthalmological Pharmaceutical Composition containing Sorafenib
#212Pharmaceutical compounds for use in the therapy of infection
#213Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#214Diagnosis, prognosis, and treatment of kidney disease
#215Method for treating chemotherapy-induced male infertility
#216Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
#217Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
#218DRUG SCREENING METHOD
#219INHIBITORS OF EYA2
#220Inhibition of renal fibrosis
#221Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance
#222Combination therapy with leukotoxin
#223Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
#224Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
#225GREEN GARLIC AND METHODS OF PRODUCTION
#226Chemosensory Receptor Ligand-Based Therapies
#227VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE
#228Method for preparing of allicin injection and low-temperature continuous stirring ultrafiltration device thereof
#229Use of at Least One Dialkyl Thiosulfonate or Thiosulfinate for Reducing the Number of Apicomplexa in an Animal
#230Method of Treating Hair Loss Due to Systemic Chemotherapy
#231Method for selectively inhibiting the activity of ACAT1 in the treatment of alzheimer's disease
#232Anti-radical agents
#233Methods of reducing virulence in bacteria
#234Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
#235Method of increasing intratumoral pHe and reducing acid-mediated invasion
#236NYASOL AND ANALOGS THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR BETA-MEDIATED DISEASES
#237FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS
#238Treatment of conditions through pharmacological modulation of the autonomic nervous system
#239Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
#240Organonitro Compounds for Use in Treating Non-Hodgkin's Lymphoma and Leukemia, and Methods Relating Thereto
#241Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#242Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis
#243METHOD OF TREATMENT OF FRAGILE X SYNDROME, DOWN'S SYNDROME, AUTISM AND RELATED DISORDERS
#244Methods for enhancing hematopoietic stem/progenitor cell engraftment
#245THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION
#246Method of selectively inhibiting the activity of ACAT1 in the treatment of Alzheimer's disease
#247Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
#248METHODS FOR PROTECTING AND REGENERATING BONE MARROW USING CXCR3 AGONISTS AND ANTAGONISTS
#249Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
#250METHOD FOR PRODUCING TABLET COMPRISING NATURAL ALLICIN
#251Green garlic and methods of production
#252NANOPARTICLE BASED THERAPY FOR AGGREGATING MUCIN
#253METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION
#254COMPOSITION
#255INHIBITION OF DEGRADATION OF EXTRACELLULAR MATRIX
#256METHOD FOR TREATING OBESITY
#257AQUEOUS FORMULATIONS OF (2-HYDROXYMETHYL-INDANYL-4-OXY)-PHENYL-4,4,4-TRIFLUOROBUTANE-1-SULFONATE
#258Tablet comprising natural allicin and method for producing the same
#259SYSTEM AND METHOD FOR ELECTROSPUN DRUG LOADED BIODEGRADABLE CHEMOTHERAPY APPLICATIONS
#260METHOD FOR TREATING AMYLOIDOSIS
#261Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
#262Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
#263NOVEL LIPID COMPOUNDS
#264Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity
#265MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
#266Substances and Pharmaceutical Compositions for the Inhibition of Glyoxalases and Their Use Against Bacteria
#267AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR
#268AGENTS AND METHOD FOR INCREASING BRAIN CHAPERONIN LEVELS
#269Compounds that inhibit human DNA ligases and methods of treating cancer
#270Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists
#271Methods for human allografting
#272COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER
#273METHODS OF USING ARYL SULFONYL COMPOUNDS EFFECTIVE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#274Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases
#275USE OF ALLICIN AS PRESERVATIVE, AS DISINFECTANT, AS ANTIMICROBIAL OR AS BIOCIDAL AGENT
#276Sulindac formulations in a biodegradable material
#277Protection of Oxidizable Agents
#278Method for determining physiological effects of hemoglobin
#279METHOD FOR EXFOLIATING SKIN
#280TREATMENT FOR SOLID TUMORS
#281Creatine ascorbyl derivatives and methods of use thereof
#282METHOD FOR TREATING OBESITY
#283Pharmaceutical Compounds
#284Methods of Inactivating Viruses
#285Method for treating obesity
#286Antipruritics
#287Anti-Radical Agents
#288Substances and Pharmaceutical Compositions for the Inhibition of Glyoxalases and Their Use As Anti-Fungal Agents
#289METHOD FOR TREATING OBESITY
#290Methods for human allografting
#291Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
#292Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#293Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis
#294Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea
#295Novel Sulfonamide derivative
#296Compositions and methods for promoting neural regeneration
#297Treatments for wound healing
#298Green garlic and methods of production
#299Sulfonated compounds and compositions for treating amyloidosis
#300Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability